Dermatol. praxi. 2010;4(1):5-9

Trends of multiple non-melanoma skin cancers in a view of their epidemiology

MUDr.Edvard Geryk1, prof.MUDr.Petr Dítě, DrSc.1, MUDr.Libuše Sedláková1, Mgr.Jiří Kozel2, Ing.Petr Koška, MBA3
1 FN Brno Bohunice
2 Geografický ústav Přírodovědecké fakulty MU, Brno
3 FN u sv. Anny, Brno

During 1970–2006 the incidence of non-melanoma skin cancers (NMSC) per 100,000 men increased from 37.2 to 172.5, from 37.0 to 150.1

per 100,000 women, the mortality from 1.2 to 1.7 per 100,000 men, from 1.0 to 1.2 per 100,000 women. The prevalence reached 1,436.4

per 100,000 men and 1,435.9 per 100,000 women up to 31. 12. 2005. From total 264,514 NMSC there were diagnosed 123,735 multiple

cases, 51.8 % in men of total registered and 41.6 % in women, represented 22.3 % primary NMSC in men, 18.2 % in women and 29.5 %

subsequent NMSC in men and 23.4 % in women. By gender there were higher 66.4 % duplicities in women and on the contrary higher

41.9 % multiplicities in men. The number of primary NMSC increased till 1994 and then decreased, of subsequent ones permanently

increased. The average length between the primary and subsequent diseases was 7.3 years, proportion of numbers of synchronous and

metachronous NMSC was 1 : 8 in men and 1 : 7.5 in women. The most frequent cancers followed after primary NMSC in men there were

other skin cancers 64.1 %, lung 6.4 %, prostate 5.5 % and colon 3.1 %, in women other skin cancers 65.2 %, breast 6.3 % and colon 3.4 %.

The most frequent primary cancers before NMSC, as the second diagnosis, there were in men cancers of prostate 20.8 % and colon 10 %,

in women cancers of breast 31.4 %, corpus uteri 13.6 % and colon 7.3 %. From patients with primary NMSC survived 37.2 % men and 44 %

women, with subsequent NMSC survived 50.8 % men and 57.2 % women up to October 2007.

and metachronous occurrence.

Keywords: non-melanoma skin cancers, incidence, mortality, prevalence, multiple diseases, primary and subsequent neoplasms, synchronous

Published: April 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Geryk E, Dítě P, Sedláková L, Kozel J, Koška P. Trends of multiple non-melanoma skin cancers in a view of their epidemiology. Dermatol. praxi. 2010;4(1):5-9.
Download citation

References

  1. Billroth CAT. Die allgemeine chirurgische pathologie und therapie. Berlin: Reimer G., 1889: 908 s.
  2. Karagas MR, et al. Risk od basal cell and squamous cell skin cancers after ionizing radiation therapy. For the skin cancer prevention study group. J. Natl. Canc. Inst. 1996; 88(24): 1848-1853. Go to original source... Go to PubMed...
  3. Marcil I, Stenr RS. Risk of developing a subsequent nonmelanoma skin cancer in patiens with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch. Dermatos. 2000; 136(12): 1524-1530. Go to original source... Go to PubMed...
  4. Raasch BA, Buettner PG. Multiple nonmelanoma skin cancer in an exposed Australian population. Int. J. Dermatol. 2002; 41(10): 652-658. Go to original source... Go to PubMed...
  5. Wassberg C, et al. Second primary cancers in patients with squamous cell carcinoma of the skin: a population-based study in Sweden. Int. J. Cancer, 1999; 80(4): 515-515. Go to original source...
  6. Geryk E, Dítě P, Pešek M, Kozel J. Následné primární novotvary u 125 262 onkologicky nemocných v České republice 1976-2005. Onkologie, 2009; 3(3): 181-189.
  7. ÚZIS: Novotvary ČR 2006. ÚZIS ČR, 2009, 256 s.
  8. Fraumeni J jr. Patterns of multiple primary cancers. In: Curtis RE, et al. New malignancies among cancer survivors: SEER cancer registries 1973-2000. NCI, NIH Publ. No. 05-5302, Bethesda, 2006: 3-5.
  9. Bhatia S. Cancer survivorship - pediatric issues. Hematology (Am. Soc. Hematom. Educ. Program), 2005; 507-515. Go to original source... Go to PubMed...
  10. van Leeuwen FE, Travis LB. Second cancers. In: DeVita VT jr., et al. (eds): Cancer: Principles and practice of oncology. 7th ed. Philadelphia: Lippincott Williams-Wilkins, 2005: 2575-2602.
  11. Curtis RE, et al. New malignancies among cancer survivors: SEER cancer registries 1973-2000. NCI, NIH Publ. No. 05-5302, Bethesda, 2006: 492 p.
  12. Konečný M, Geryk E, Kubíček P, a kol. Prevalence nádorů v České republice 1989-2005. PřF MU Brno, 2008: 69 s.
  13. Hoey SE, et al. Skin cancer trends in Northern Ireland and consequences for provision of dermatology services. Br. J. Dermatol. 2007; 156(6): 1301-1307. Go to original source... Go to PubMed...
  14. Plesko I, Severi G, Obsitníkové A, Boyle P. Trends in the incidence of non-melanoma skin cancer in Slovakia, 1978-1995. Neoplasma, 2000; 47(3) 137-42. Go to PubMed...
  15. Abdulla FR, et al. Tanning and skin cancer. Pediatr. Dermatol. 2005; 22(6): 501-512. Go to original source... Go to PubMed...
  16. Rigel DS. Cutaneous ultraviolet exposure and its relationship to the development of skin cancer. J. Am. Acad. Dermatol. 2008; 58(Suppl. 2): 129-132. Go to original source... Go to PubMed...
  17. Tuohimaa P, et al. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. Eur. J. Cancer 2007; 43(11): 1701-1712. Go to original source... Go to PubMed...
  18. Soerjomataram I, et al. Are patients with skin cancer at lower risk of developing colorectal or breast cancer? Am. J. Epidem. 2008; 167(12): 1421-1429. Go to original source... Go to PubMed...
  19. Rhodes AR. Public education and cancer of the skin. Cancer, 1995; 15(75, 2 Suppl.): 613-636. Go to original source...
  20. Edlich RF, et al. National health strategies to reduce sun exposure in Australia and the United States. J. Long Term. Eff. Med. Implants. 2004; 14(3): 215-224. Go to original source... Go to PubMed...
  21. Staples MP, et al. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med. J. Aust. 2006; 184(1): 6-10. Go to original source... Go to PubMed...
  22. http://zdravi.geogr.muni.cz.




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.